Related Experiment Videos
2,3,7,8-Tetrachlorodibenzo-p-dioxin: failure to demonstrate toxicity in twenty-three cultured cell types
Toxicology and Applied Pharmacology
|July 1, 1980
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Growth inhibition of cancer cells by an active metabolite of a novel vitamin D prodrug.
Anticancer research·2005
An epizootic of highly virulent feline calicivirus disease in a hospital setting in New England.
Journal of feline medicine and surgery·2003
Clinical, microscopic, and molecular aspects of canine leproid granuloma in the United States.
Veterinary pathology·2002
Chronic inhalation of m-Xylene disrupts vascular homeostasis through endothelial injury and impaired vascular repair.
Toxicology and applied pharmacology·2026
Cardioprotective effects of melatonin in vitro and in two in vivo models of heart disease: Isoproterenol-induced cardiac injury and pulmonary hypertension.
Toxicology and applied pharmacology·2026
Lateral line - evoked potentials (LLEPs): an effective tool for investigating ototoxicity.
Toxicology and applied pharmacology·2026
Early life respiratory syncytial virus infection enhances cadmium-induced lung toxicity through protein S-palmitoylation.
Toxicology and applied pharmacology·2026
Mangiferin monosodium salt attenuates metabolic and alcohol-associated liver disease via a novel insight into cuproptosis and improving gut microbiota.
Toxicology and applied pharmacology·2026
Network pharmacological combined with in vivo and in vitro validation reveals the mechanisms of atrazine-induced Parkinson's disease-related neurotoxicity.
Toxicology and applied pharmacology·2026
Programmed cell death in degenerative skeletal diseases: molecular crosstalk and combinatorial therapeutic strategies.
Frontiers in cell and developmental biology·2026
Modeling Risk Group 4 virus infection and antiviral treatment in microfluidic lung organ-on-chips in maximum containment laboratories.
bioRxiv : the preprint server for biology·2026
Orforglipron: An Oral GLP-1 Receptor Agonist for Obesity Treatment.
The Annals of pharmacotherapy·2026
Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early-Grade Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial.
International journal of rheumatic diseases·2026